Daily Oncology News

Recommended Therapies for Polycythemia Vera Underused

Recommended Therapies for Polycythemia Vera Underused

Phlebotomy and hydroxyurea tied to improved survival, lower risk for thrombosis in older patients.

FDA Grants Approval to New Treatment for Acute Myeloid Leukemia

FDA Grants Approval to New Treatment for Acute Myeloid Leukemia

Randomized clinical trial showed significant improvement in overall survival with glasdegib.

Immunotherapy Side Effects May Be More Common Than Thought

Immunotherapy Side Effects May Be More Common Than Thought

Higher rates of adverse events observed for immune checkpoint inhibitors in real-world settings, compared to clinical trials.

Obesity as a Teen Ups Risk for Later Pancreatic Cancer

Obesity as a Teen Ups Risk for Later Pancreatic Cancer

In men, overweight and even higher normal weight is associated with an increased risk of future pancreatic cancer.

Patients and Caregivers Worry About Cost of Cancer Care

Patients and Caregivers Worry About Cost of Cancer Care

Survey also shows that Americans may be misinformed about alternative treatments for cancer.

Head and Neck Cancer Survivors Have Increased Suicide Risk

Head and Neck Cancer Survivors Have Increased Suicide Risk

Survivors of head, neck cancers almost twice as likely to die from suicide as survivors of other cancers.

AAD Releases New Guidelines for the Treatment of Cutaneous Melanoma

AAD Releases New Guidelines for the Treatment of Cutaneous Melanoma

Guidelines recommend surgical excision as primary treatment modality, and emphasize individualized care.

Barriers to Prostate Cancer Research in Black Men Identified

Barriers to Prostate Cancer Research in Black Men Identified

Mistrust, lack of knowledge, unfavorable attitudes are barriers to genomic testing, study participation

New Method Estimates Risk for Breast Cancer Recurrence

New Method Estimates Risk for Breast Cancer Recurrence

Higher recurrence risk linked to older age, more advanced stage, HR-negative tumors.

Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer

Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer

Atezolizumab plus nab-paclitaxel prolongs progression-free survival in metastatic disease.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs